Effect of early cross-over on survival curves in clinical trials

被引:0
|
作者
Guddati, Achuta Kumar [1 ]
机构
[1] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA
关键词
D O I
10.1200/jco.2015.33.15_suppl.e17616
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e17616
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Analysis of cross-over trials for duration data
    Lindsey, JK
    Jones, B
    Lewis, JA
    STATISTICS IN MEDICINE, 1996, 15 (05) : 527 - 535
  • [22] The case for cross-over trials in phase III
    Senn, S
    STATISTICS IN MEDICINE, 1997, 16 (17) : 2021 - 2022
  • [23] M-ESTIMATION IN CROSS-OVER TRIALS
    CHI, EM
    BIOMETRICS, 1994, 50 (02) : 486 - 493
  • [24] Estimation of Treatment and Carryover Effects in Optimal Cross-Over Designs for Clinical Trials
    Divecha, Jyoti
    Gondaliya, Jignesh
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2015, 7 (02): : 95 - 105
  • [25] Pseudoneglect and the cross-over effect
    Rueckert, L
    Deravanesian, A
    Baboorian, D
    Lacalamita, A
    Repplinger, M
    NEUROPSYCHOLOGIA, 2002, 40 (02) : 162 - 173
  • [26] A novel approach to adjust for the impact on survival resulting from patient cross-over from control to experimental treatment in clinical trials
    Ishak, K. J.
    Deniz, B.
    Drayson, M.
    Morgan, G. J.
    Augustson, B. M.
    Child, J. A.
    Begum, G.
    Dunn, J. A.
    Shearer, A.
    Caro, J. J.
    VALUE IN HEALTH, 2008, 11 (03) : A155 - A155
  • [27] THE CASE FOR CROSS-OVER TRIALS IN PHASE-III
    JONES, B
    LEWIS, JA
    STATISTICS IN MEDICINE, 1995, 14 (9-10) : 1025 - 1038
  • [28] THE OPTIONAL CROSS-OVER DESIGN FOR RANDOMIZED CONTROLLED TRIALS
    ERNST, E
    RESCH, KL
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1995, 9 (05) : 508 - 511
  • [29] A model for cross-over trials evaluating therapeutic preferences
    Lindsey, JK
    Jones, B
    STATISTICS IN MEDICINE, 1996, 15 (04) : 443 - 447
  • [30] Cross-over trials in drug development: theory and practice
    Senn, S
    JOURNAL OF STATISTICAL PLANNING AND INFERENCE, 2001, 96 (01) : 29 - 40